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Abstract
Background Although stoma closure is considered a simple
surgical intervention, the interval between construction and
reversal is often prolonged, and some ileostomies may never
be reversed. We evaluated possible predictors for non-reversal
and prolonged interval between construction and reversal.
Material and methods In a cohort study of ileostomy patients
treated in a large teaching hospital, we collected data from the
surgical complication and enterostomal therapists’ registries
between January 2001 and December 2011. Parameters re-
sponsible for morbidity, mortality, length of stay and time
interval between construction and reversal were analysed.
Results Of 485 intentionally temporary ileostomies, 359
were reversed after a median of 5.6 months (IQR 3.8–
8.9 months), while 126 (26 %) remained permanent.
End ileostomy and intra-abdominal abscess independently
delayed reversal. Age, end ileostomy, higher body mass index
and preoperative radiotherapy were independent factors for
non-reversal. Median duration of hospitalisation for reversal
was 7.0 days (5–13 days). Morbidity and mortality were 31
and 0.9 %, respectively. In 20 patients (5.5 %), re-ileostomy
was necessary.
Conclusions A substantial number of ileostomies that are
intended to be temporary will never be reversed. If reversed,
the interval between construction and reversal is longer than
anticipated, while morbidity after reversal and duration of
hospitalisation are considerable. Besides a temporary
ileostomy, there are two other options: no diversion or a per-
manent colostomy. Shared decision-making is to be preferred
in these situations.
Keywords Defunctioning stoma . (temporary) Ileostomy .
Reversal . Takedown . Prediction
Introduction
Although the potential benefits of a defunctioning ileostomy
are clear, stoma-related morbidity is known to be high [1, 2].
Recent literature shows overall stoma-related morbidity
among various patient populations, and using different types
of stomata may vary between 17 and 45 % [1–3]. Stomata
have also been shown to negatively influence quality of life
and body image [4, 5]. Despite prior counselling, many pa-
tients remain distressed with the thought of having a stoma
and are keen to get it closed as early as possible. Hence, both
surgeons and patients look forward to an early closure of the
stoma.
When creating a diverting ileostomy, the aim is to reverse it
after 6–12 weeks [2, 6, 7].
There are no set protocols for stoma closure [8]. Scheduling
of reversal is extremely variable among hospitals [9]. In several
studies, time to closure was considerably longer (ranging from
13 to 37 weeks). This may be due not only to prolonged recov-
ery following initial surgery, development of complications
after creation and adjuvant treatment but also administrative
delays such as waiting lists for cancer surgery or other urgent
procedures [2, 10]. As a result, patients sometimes retain their
stoma much longer than initially proposed, with an inherent
impact on their physical and psychological well-being as well
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as on the healthcare budget [10]. Furthermore, not all tempo-
rary ileostomies are reversed; 3–25 % of these ileostomies be-
come permanent [1, 9–11].
Even though ileostomy reversal is generally considered a
simple procedure, it can also have a severe impact on the
patient, with morbidity rates up to 45 % [2, 12, 13]. A com-
plicated clinical course after closure can also have a deleteri-
ous effect on the patient’s quality of life.
The aim of this study was to assess various aspects
of stoma closure, i.e. frequency of closure, time interval,
morbidity (e.g. anastomotic leakage, enterocutaneous fis-
tula, postoperative bleeding, stoma site infection), mor-
tality, possible risk factors for delay in reversal and
possible predictors for non-closure in an 11-year cohort
of ileostomy patients to better counsel patients (and sur-
geons) on a possibly delayed or even non-reversal of an
ileostomy.
Patients and methods
The conduct and description of this cohort study were per-
formed according to the STROBE statement [14].
Design and setting
In this patient cohort, all ileostomies constructed between Jan-
uary 2001 and January 2012 in the Albert Schweitzer Hospital
in Dordrecht, a large secondary referral and teaching hospital
in the Netherlands, were studied. Patient follow-up was until
March 2013.
Patient selection
We searched for all patients (children and adults) who
had undergone a loop or end ileostomy and selected
those who were intended to be reversed. Excluded were
patients who had received an ileostomy deemed perma-
nent from the beginning.
Eligible patients were retrieved from the database of
the enterostomal therapists, who were involved in the
instruction, preparation and follow-up care of all pa-
tients receiving a stoma. We also searched the hospital’s
surgery registration database for stoma reversal proce-
dures to make sure all patients from that period were
included.
Reversal procedure
A colorectal surgeon or a surgical resident under the di-
rect supervision of a colorectal surgeon carried out closure
of the ileostomy under general anaesthesia. All patients
were given antibiotic prophylaxis: amoxicillin and
clavulanic acid 2.2 g and aminoglycoside 4 mg per kg
intravenously 1 h preoperatively. Ileostomies were closed
by means of a running suture or a stapled closure, depend-
ing on the preference of the (supervising) surgeon.
The stoma was dissected from the mucocutaneous
junction and delivered from the rectus sheath and perito-
neal cavity by sharp dissection. Loop ileostomies were
closed extraperitoneally (if possible) and end ileostomies
intraperitoneally by means of a running suture or a stapled
closure, depending on the preference of the (supervising)
surgeon. The posterior and anterior rectus sheaths were
closed to minimise the risk of an incisional hernia. The
wound was partially left open to prevent wound infec-
tions. After surgery, the nasal gastric tube was removed,
and the patient started a normal diet as soon as possible.
Patients were discharged if they tolerated a normal diet,
had stool and could take care of the wound. The patient
was scheduled to visit the outpatient clinic 2 weeks after
discharge.
Data collection
Patient characteristics, surgery-related data and stoma-
related complications were collected from the hospital’s
surgical complication registration Database combined
with the prospectively collected dataset of the enteros-
tomal therapists (EI version 4.0 for Windows,
Combicare, Gouda, the Netherlands). Two surgical resi-
dents collected the data. A standard data extraction form
was used in the retrieval process. Data were checked for
completeness and accuracy by means of random sam-
pling by one of the supervising surgeons. A complica-
tion was defined as a postoperative, stoma-related
complication.
We registered age, gender, body mass index (BMI),
American Society of Anesthesiologists (ASA) classifica-
tion, indications for ostomy surgery (malignancy, in-
flammatory bowel disease, diverticulitis, complications
after surgery, ileus or trauma), comorbidities, time be-
tween stoma construction and reversal, morbidity, mor-
tality rate and reoperations after reversal, when and why
a new stoma had to be constructed, as well as follow-up
data of the patients. BNon-reversal^ was defined as a
stoma being still present at the end of follow-up. Rea-
sons for not closing the stoma were recorded and
analysed.
Statistical analysis
Outcome variables are presented as means and standard
deviations (SD) or medians and interquartile ranges
(IQR), if not normally distributed. Differences in dichot-
omous outcomes are expressed as risk differences
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including their 95 % confidence intervals (CI). Differ-
ences in continuous variables were analysed with the
Mann-Whitney U test because of the non-normal distri-
bution. Kaplan-Meier curves including log-rank testing
were used to present and compare crude proportions of
non-reversal.
Multivariable stepwise logistic regression analysis
was performed to detect independent factors associated
with eventual stoma closure, expressed as odds ratios
(OR) with 95 % CIs. Based on this multivariable logis-
tic regression analysis, we defined a formula to predict
the chance of non-reversal.
Also a multivariable Cox proportional hazards analy-
sis was done to calculate the hazard ratios (HR) of
factors influencing the time interval before stoma clo-
sure. Differences were considered significant at P<0.05.
Factors possibly predicting non-reversal or delayed clo-
sure of the ileostomy were selected based on clinical
relevance and prior univariable analysis.
All calculations were performed using the Statistical Pack-
age for the Social Science (SPSS) for Windows (version 20;
IBM SPSS Inc., Armonk, NY, USA).
Results
Participants
Between 2001 and 2012, 572 ileostomies were constructed.
Of these, 485were intended to be temporary. The flow chart of
patient inclusion is shown in Fig. 1.
Baseline characteristics of the included patients are
displayed in Table 1. Most of the patients in this study re-
ceived a loop ileostomy to divert low anastomoses after rectal
excision for malignancy. An end ileostomy was performed
mostly in patients who needed a resection for irritable bowel
syndrome, for example, a proctocolectomy or a subtotal
colectomy. Median follow-up was 22.6 months (IQR 10.1–
46.0).
The stoma remained permanent in 126 of the 485
patients (26 %). In 56 patients, closure was considered
contraindicated because of high comorbidity (9.8 %). Re-
versal was refused by 25 patients (4.4 %), one patient
had its ileostomy closed in another hospital, and in 45
patients, reversal was not accomplished (7.9 %) of whom
21 patients died after initial surgery, for example, be-
cause of anastomotic leakage or bowel ischemia. Twelve
patients died because of other reasons, like exacerbation
of ulcerative colitis, non-Hodgkin lymphoma, kidney
failure, myocardial infarction or disease progression. At
the last follow-up, 7 patients still had active disease and
reversal was not yet possible, for example, because of
perianal fistula, presacral sinus and disease recurrence.
In 5 patients, it was not clear why reversal had not yet
been accomplished.
In 20 patients, the stoma had to be reconstructed again, for
example, due to anastomotic leakage, stenosis and inconti-
nence; 11 patients after reversal of a loop ileostomy and 9
patients after reversal of an end ileostomy. We found a risk
difference of 9.2 % (0.1 %–17.4 %) in favour of the loop
ileostomy group.
Ileostomy reversal
Stoma reversal rates for each of the underlying diseases are
shown in Table 2. Stoma reversal was possible in 79 % after
surgery for malignancy, in 67 % for benign disease and in
82 % of the loop ileostomies and 53 % of the end ileostomies;
26 %(n=126) of the intentionally temporary ileostomies were
never reversed, while in patients with stomata that were
intended to be closed, 88 % of these were closed within a year
(Table 2).
Risk factors for non-reversal
In the multivariable logistic regression analysis, the fol-
lowing possibly associated factors were entered: con-
struction of the ileostomy in an elective or in an acute
setting, stoma-related complications after stoma creation
as well as anastomotic leakages despite defunctioning
stoma (for example leading to a presacral sinus), stoma
retraction and so on, the responsible surgeon, type of
ileostomy, (neo) adjuvant therapy, ASA classification,
BMI, re-laparotomy after creation, revision of stoma
and indication for surgery. These factors were selected
based on clinical relevance and the univariable analysis.
Independent predictors for non-reversal were found to
be end ileostomy, preoperative radiotherapy, BMI and
higher age (Table 3). The odds for reversal in patients
with a loop ileostomy were 4.3 times higher than in pa-
tients with an end ileostomy. The odds for reversal de-
creased with 3 % per year increase in age (OR 0.97). Each
point increase in BMI was associated with a small but
significant 7 % higher chance of reversal. Anastomotic
leakage was not found to be an independent predictor of
eventual non-reversal.
Based on our multivariable logistic regression analysis, we
could define the following formula to predict the chance of
reversal when a patient has one or more of the risk factors
found (Table 3).
Ln odds for non‐reversalð Þ ¼ 1:535−0:34 age
− 1:030 preoperative radiotherapy
þ 1:454 loop ileostomy
þ 0:65 BMI
Int J Colorectal Dis (2015) 30:1185–1192 1187
For example, if we have a patient of 50 years old with a
BMI of 24 and who underwent preoperative radiotherapy and
received a loop ileostomy, the chance that the ileostomy will
not be closed is 64 %:













Risk factors for delay in reversal
Median time to reversal was 5.6 months (IQR 3.9–9.0). In the
multivariate Cox regression analysis, the following factors
were entered: construction of an ileostomy in an elective or
in an acute setting, (stoma-related) complications after crea-
tion, operating surgeon, type of ileostomy, (neo) adjuvant ther-
apy, ASA classification, BMI, re-laparotomy after creation,
revision of stoma and indication for surgery. These factors
were selected based on clinical relevance and the univariable
analysis.
Independent factors for delayed reversal were an end
ileostomy, an intra-abdominal abscess, diverticulitis or
complications after initial surgery necessitating the con-
struction of an ileostomy (Table 4). As shown in Table 4
and Fig. 2, when considering the eventually reversed
ileostomies, loop ileostomies were reversed significantly
faster than end ileostomies (HR 0.378, P<0.001).
Patients with an intra-abdominal abscess after initial sur-
gery had a higher risk of delay in reversal than patients
without an abscess (HR 0.706, P=0.021). Ileostomies in
patients with diverticulitis and in patients who had a
complication after initial surgery were reversed signifi-
cantly sooner than for a malignancy (resp. HR 1.424,
P=0.026 and HR 1.827, P=0.002).
Median hospital stay was significantly (P<0.001) longer
after closure of end ileostomies (11 days, IQR 7.50–17.50) as
compared with loop ileostomies (7 days, IQR 5.0–11.5). No
trend towards a shorter hospital stay over the years was
observed.
Postoperative complications occurred in 112 of the
359 reversal procedures (31 %), while 20 patients
sustained more than one complication (5.5 %). In 20
patients, a new stoma had to be constructed because
of complications (6 %); in 4 % of the loop ileostomies
that were closed and 12 % of the end ileostomies.
Fig. 1 Overview of patient
inclusions and outcomes
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Reasons for the creation of a new stoma were anasto-
motic leakage, stenosis, abscesses, fistula or pouchitis.
Stoma-related mortality after stoma reversal was 0.9 %
(n=5).
Discussion
Although literature suggests that temporary ileostomies can
safely be reversed in due time, the interval between construc-
tion and reversal is often very long, and a large proportion of
the stomas will never be reversed. The present study shows
that in a large cohort of temporary stomas, only 71 % of the
loop ileostomies and 43 % of the end ileostomies were closed
eventually. Median interval to closure was nearly half a year.
The non-reversal percentage in this study is even higher
than previously observed in the literature. Other studies
showed non-reversal rates ranging from 9 to 25 % [1, 2, 9,
12, 15]. This discrepancy can in part be explained by our study
population, which also included patients who received an
ileostomy for other reasons than a malignancy.
Older age, lower BMI, end ileostomy and preoperative
radiotherapy are found to be independent factors associated
with non-reversal. Besides, our predictionmodel indicates that
if a patient would have all risk factors, he has a 64 % risk that
his ileostomy will not be reversed. The literature confirms our
finding that age is associated with non-reversal [1, 9, 11, 16].
In patients over 70 years, one out of three ileostomies became
permanent [9]. Probably this is due to a higher comorbidity
rate and unwillingness to be operated again. Den Dulk et al.
found similar results for end ileostomies [1]. However, they
also found postoperative complications and recurrence to be
risk factors, which we could not confirm.
End ileostomies rather than loop ileostomies are more
prone to a delay before closure and even to become perma-
nent. Loop ileostomies are typically constructed to divert a
downstream anastomosis and can be closed locally. End
ileostomies are more often made after intestinal resection
where immediate re-anastomosing is considered to be unsafe.
Perhaps this also explains why after closure of an end
ileostomy, the chance of reconstruction of a new stoma due
to complications after reversal is higher due to the fact that
closure must be done by laparotomy or laparoscopy. Surgeons
should be aware of these disappointing figures and include
these in their decision-making about creating a temporary sto-
ma against the risk of increased morbidity or deciding for a
permanent stoma. We believe that these disappointing results
are due to the fact that especially during the first years of the
study, almost all surgeons in our hospital and probably also in
our country were quite conservative in performing a primary
anastomosis protected by a loop ileostomy and preferred an
end ileostomy without an anastomosis.
In our study, preoperative radiotherapy reduced reversal
rates. However, in the study of Lindgren et al., preoperative
radiotherapy was not an independent risk factor for non-
reversal [11]. Furthermore, in our experience, a small group
of patients eventually accepted having a stoma for a longer
period, as they preferred to be disease-free after their eventful
period during the past year.
Diverting ileostomies are mostly constructed to protect a
downstream anastomosis. It is known that the leakage rate will
Table 3 Results of multivariable logistic regression analysis
B P value OR 95 % CI for HR
Lower Upper
Age −0.034 0.000 0.967 0.949 0.985
Preoperative radiotherapy −1.030 0.007 0.357 0.170 0.751
Loop ileostomy 1.454 0.000 4.280 2.288 8.007
BMI 0.065 0.028 1.067 1.007 1.130
Constant 1.535 0.094 4.639
OR<1 indicates decreased likelihood for stoma reversal
Table 1 Baseline patient characteristics
Gender Male 207 (58 %)
Age (years) 64.3 IQR (54.7–72.8)
BMI 25 IQR (23.0–28.8)
ASA 1 73 (20 %)
2 228 (64 %)
≥3 58 (16 %)
Ileostomy Loop 289 (81 %)
End 70 (19 %)
Surgery Elective 304 (86 %)
Acute 50 (14 %)
Reason Malignancy 217 (60 %)
Benign 142 (40 %)
Data are presented as percentages or medians with interquartile ranges
(IQR)
BMI body mass index, ASA American Society of Anaesthesiologists
classification
Table 2 Reversal rates per indication
Indication Reversed ileostomies Total ileostomies
Malignancy 210 (79 %) 267
Inflammatory bowel disease 30 (59 %) 52
Diverticulitis 51 (80 %) 64
Ileus 10 (63 %) 16
Complication after surgery 35 (85 %) 41
Other reasons 23 (51 %) 45
Total 359 (74 %) 485
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be reduced by one third to one half and that the clinical con-
sequences are mitigated [7, 17, 18]. Depending on the leak
rate of the specific anastomosis, most diverting ileostomies are
constructed only as a precaution. A balanced decision should
be made with the patient whether or not to protect the down-
stream anastomosis. Since the non-closure rate of end
ileostomies is considerable, one could argue that re-
anastomosing combined with a diverting ileostomy might be
the better option or even to choose for no diversion or a per-
manent colostomy. These considerations make shared
decision-making with the patient important [19]. The same
accounts for the decision to restore the continuity after rectal
resection.
Existing literature does not provide a protocol for op-
timal closure and timing of closure for ileostomies [8].
However, most surgeons would prefer to close the
ileostomy as soon as the patient is medically fit and
willing [10]. After 10–14 days, inflammatory adhesions
around the stoma will interfere with stoma closure. A
period of at least 6–10 weeks is required for the inflam-
matory adhesions to subside. It has been shown that in
selective patients, e.g. those who recover quickly after
the initial surgery, the stoma can be closed within these
10–14 days avoiding a longer period of having a stoma
with the associated problems and costs [6, 17]. The ma-
jority of patients experience an overall improvement of
quality of life, physical functioning and social function-
ing following stoma closure [20] .
Time to reversal was found to be much longer than antic-
ipated, which was similar to other studies in which median
time to reversal ranged from 4.1 to 5.9 months [1, 2]. In con-
trast, however, in a recent systematic review, in which the
Fig. 2 Kaplan-Meier curve of the
number of not (yet) reversed
Table 4 Results of multivariate
Cox regression analysis P value HR 95 % CI for HR
Lower Upper
End ileostomy 0.000 0.378 0.275 0.520
Abscess 0.021 0.706 0.526 0.948
Reason for surgery compared to malignancy 0.009
Diverticulitis 0.026 1.424 1.044 1.942
Complication after initial operation 0.002 1.827 1.250 2.670
HR<1 indicates higher risk of delayed reversal
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results by Den Dulk and Gessler were (strikingly) not includ-
ed, the average time between ileostomy creation and closure
was found to be 10.8 weeks [12]. Our study does not confirm
the results of this review. One of the reasons for the delay in
stoma closure is that stoma closure is considered an elective,
low-priority operation that has to compete with more complex
and urgent operations. To get around this particular problem,
some advocate that setting a date for stoma closure at dis-
charge helps early closure of ileostomies [10].
In our study, 26 % of the temporary ileostomies were not
reversed, and if they were, reversal was not without morbidity
and even mortality. This means that one out of four patients
received a permanent stoma, while in a small percentage of the
patients, another stoma had to be constructed because of anas-
tomotic leakage or because of faecal incontinence. The com-
plication rate we found after reversal is higher than the data
given in the Chow review. This is probably due to the long
follow-up, even after closure, in our patient series.
Strengths and limitations of this study
The strength of this study is the large size of our patient series
with intentionally temporary ileostomies with a long follow-up,
which gives a good insight into the practice of a large second-
ary referral and teaching hospital in the Netherlands.
A limitation of this study is its retrospective nature. As
such, it has its possible sources of bias. However, the data
were collected from the hospital’s surgical complication reg-
istration database combined with the prospectively collected
dataset of the enterostomal therapists, which warrants an ex-
tensive and reliable registry.
Second, our patient group was rather heterogeneous. How-
ever, this variety in patient mix was a stipulation to assess
possible risk factors. On the other hand, this was a single-
centre study with a limited group of patients and surgeons
who cared for them. Therefore, we believe the results of this
study are valid and may well be applicable to other centres.
Conclusion
A substantial number of ileostomies that are intended to be
temporary will never be reversed. In case of reversal, the mor-
bidity is considerable. The interval between construction and
reversal and the length of hospital stay are substantially longer
than usually assumed. It is essential that surgeons are aware of
these findings and tailor their surgical strategy to the patients
and its disease keeping this in mind. Besides a temporary
ileostomy, there are two other options: no diversion or a per-
manent colostomy. Shared decision-making is to be preferred
in these situations [21].
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